SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0000950123-09-031294
Filing Date
2009-08-06
Accepted
2009-08-06 17:02:42
Documents
5
Period of Report
2009-06-30
Filing Date Changed
2009-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q g19751e10vq.htm 10-Q 1407609
2 EX-31.1 g19751exv31w1.htm EX-31.1 8976
3 EX-31.2 g19751exv31w2.htm EX-31.2 8969
4 EX-32.1 g19751exv32w1.htm EX-32.1 3697
5 EX-32.2 g19751exv32w2.htm EX-32.2 3689
  Complete submission text file 0000950123-09-031294.txt   1434307
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15875 | Film No.: 09992414
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1